Complex disease genomics

Understanding the Genetics of Neurodevelopmental Disorders

Australian researchers are using NGS to study intellectual disabilities

Understanding the Genetics of Neurodevelopmental Disorders
18 February 2016

As an Australian Research Council Fellow at The University of
Adelaide, Dr. Lachlan Jolly is involved in research programs to identify and study genes responsible for neurological disorders. To discover novel gene variants and describe their role in intellectual disability, Dr. Jolly integrates cell-based models with a multitude of genetic and functional genomic technologies.

The team is working to discover the effects of genetic change and specifically what functional effect gene variants have on the development of the brain and how they affect the way the cells behave and communicate. Dr. Jolly and his colleagues use next-generation sequencing (NGS) on Illumina’s HiSeq systems to gain insight into the novel genetic networks important for brain development and function. For more on Dr. Jolly’s research, click here.

Recent Articles

The rare disease community fights for precision medicine, from diagnosis to cure
The rare disease community fights for precision medicine, from diagnosis to cure
Admera Health uses the NovaSeq X Plus to expand capabilities
Admera Health uses the NovaSeq X Plus to expand capabilities
How Illumina employees step up, reach out, and give back
How Illumina employees step up, reach out, and give back